FindTrial
Sign In

Shanghai Lymphoma Clinical Cohort (SHDC2025CCS008)

Shanghai Lymphoma Clinical Cohort

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111270
Enrollment
Unknown
Registered
2025-10-29
Start date
2025-10-30
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoma

Interventions

Observation group:None

Sponsors

Shanghai Ruijin Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who are 18 years of age or older and have been diagnosed with non-Hodgkin lymphoma.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1. Currently using specific prohibited medications; 2. Fitted with specific devices (e.g., cardiac pacemaker); 3. Pregnant or breastfeeding; 4. Allergic to the research intervention; 5. Had a febrile illness within a specified time period; 6. Used other investigational drugs within a specified time period; 7. Smoker within a specified time period; 8. Has designated diseases or conditions (physical or psychological, physical examination findings) that exclude participation in the study.

Design outcomes

Primary

MeasureTime frame
Progression-free survival;—

Countries

China

Contacts

Public ContactWeili Zhao

Shanghai Ruijin Hospital

zwl_trial@163.com+86 21 6437 0045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026